Grant: BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
Primary Recipient
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
Amount
$304,444.00
Award Date
8/31/2009
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Chronic myeloid leukemia (CML) results from transformation of a primitive hematopoietic cell by the BCR-ABL gene. The BCR-ABL tyrosine kinase (TK) inhibitor imatinib is highly effective in inducing remissions and improving survival in CML patients but doe